Sitemap

April 21, 2005 Articles

Filter by Available Specialty
  1. Alendronate therapy linked to severely suppressed bone turnover
  2. B&L sales up during first quarter
  3. Pfizer revenue up for quarter; latanoprost leading ophthalmic drug
  4. Senator calls for more physician involvement in politics
  5. Visudyne leads Novartis ophthalmic sales in first quarter 2005